Literature DB >> 3933763

Opiate antagonist facilitation of time-dependent memory processes: dependence upon intact norepinephrine function.

M Gallagher, P R Rapp, R J Fanelli.   

Abstract

Post-training administration of opiate antagonists improves retention of recent learning in laboratory animals tested on a variety of tasks. We examined the possibility that this effect of opiate antagonist treatment might be due to release of brain norepinephrine (NE) function from opioid peptide inhibition. The behavioral testing procedure in the experiments consisted of one-trial passive avoidance conditioning. Rats received post-training treatments immediately after the training trial and retention was tested 24 h later. Lesions of the dorsal noradrenergic bundle (DNB) that were induced by 6-hydroxydopamine (6-OHDA) were found to prevent the memory enhancing effect of post-training naloxone administration. The memory enhancing effect of naloxone was restored when NE neurons were protected from 6-OHDA by pretreatment with a NE uptake inhibitor. Earlier research indicated that the amygdala complex is one brain site that is sensitive to the effects of opiate manipulations on memory processes. In this study, lesions of the DNB were also found to prevent the memory enhancing effect of intracranial opiate antagonist administration into the amygdala complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933763     DOI: 10.1016/0006-8993(85)90188-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Peripheral modulation of learning and memory: enkephalins as a model system.

Authors:  G Schulteis; J L Martinez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

4.  Cognitive effects of high-dose naltrexone in patients with probable Alzheimer's disease.

Authors:  D S Knopman; M Hartman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

5.  Naloxone and beta-endorphin alter the effects of post-training epinephrine on memory.

Authors:  I B Introini-Collison; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  "Silent" metaplasticity of the late phase of long-term potentiation requires protein phosphatases.

Authors:  Newton H Woo; Peter V Nguyen
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

7.  Involvement of the amygdala in the memory-enhancing effects of clenbuterol.

Authors:  I B Introini-Collison; B Miyazaki; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.